4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001628280-26-002961
CFO & Chief Business Officer acquired 99,133 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO & Chief Business Officer | 2026-01-16 | Grant or award | +99,133 | 309,084 | D | ||
| Derivatives | |||||||
| Zuga Matt CFO & Chief Business Officer | 2026-01-16 | Grant or award · Employee Stock Option (right to buy) | +148,700 | 148,700 | D | ||
Loading xslF345X05/wk-form4_1769038322.xml…